NCOR2 and proximal spinal muscular atrophy: Comparison between type III-IV and type I SMA male patients demonstrated a 16% decrease in methylation levels of the CpG4 target site belonging to the 5’UTR of NCOR2. This is consistent with the data of whole genome methylation analysis that identified lower methylation levels of the CpG4 target site in healthy individuals [18].